Introduction
Prostatic carcinoma is the most common cancer in men in the USA and Europe. It is the second cause of cancer death among men (1) . Bladder neck (BN) involvement (BNI) after radical prostatectomy has been a matter of debate for many years. In the fourth edition of the American Joint Committee on Cancer (AJCC) staging manual published in 1992, it was classified in pT4 category, showing the extension of the tumor into the adjacent organs such as the rectum, external sphincter or the pelvic wall musculature (2). Since then, several studies have been published discussing whether it should be classified as pT3 or pT4. Since BN sparing surgeries are preferred to avoid postoperative incontinence, it is important to make a proper substaging. In radical prostatectomy materials, there were many different BNI definitions. Consequently, it is classified as microscopic and macroscopic involvement (3). One of the two studies by Yossepowitch et al. (4) with a larger population cohort study with heterogeneous features, it was reported that sole BNI did not predict prostate-specific antigen (PSA) recurrence in a multivariate model and pT4 was suggested to be reserved for macroscopic or radiographic BNI instead of microscopic BNI. In their multiethnic, multicenter study, Buschemeyer et al. (5) concluded that a positive BN margin associated with other positive margins had a progression risk similar to seminal vesicle (SV) invasion (pT3b), however, an isolated BN margin was found to be a rare event. However, this data needs to be supported by large cohorts due to the limited number of patients. Additionally, patients with positive BN margin had higher PSA level, greater Gleason score, higher rates of extraprostatic extension (EPE), SV involvement, and positive surgical margins (5). Zhou et al.
(6) grouped microscopic BNI as true and false. True BNI had prostatic carcinoma within thick smooth muscle bundles without intermixed benign prostatic glands (Figure 1a ), and false BNI had prostatic carcinoma intermixed with benign prostatic glands (Figure 1b) . Regardless of this categorization, both groups had increased biochemical recurrence risk. According to this study, microscopic BNI should be staged between pT2 and pT3, and pT4 should be limited to gross or radiographic invasion, consistent with some of the previous studies (6) . A large study (17000 patients) with a long time period (1982-2008) by Pierorazio et al. (7) supported the significance of a BNI after radical prostatectomy concordant with the study by Zhou et al. (6) . They also used the true-false BNI term and found that biochemical recurrence-free and cancer-specific survival rates were similar to pT3a and pT3b, respectively. They also suggested that BNI could be settled into pT3a similar to EPE or placed into pT3b by pushing SV involvement to pT3c. The study emphasized that BNI should not be designated as stage pT4, in which the patients were rarely treated by surgery. On the contrary, this group of tumors can be resected or treated. This study also advocates their data's reliability with their quite large cohort and 25-year single institution follow-up (7). After similar several studies, change was inevitable, and microscopic BNI was carried from pT4 to pT3a category in the seventh edition of the AJCC manual (3). Recently, a group of Korean urologists published a study supporting the validity of this change both in isolated positive BNI and BNI with another surgical margin positivity (8) . After well designed and multiple large studies conducted with appropriate patient populations, BNI substaging remained the same in the 8 th edition of the AJCC manual (9) . However, as both the prostate team of the AJCC and Silberstein and Eastham (10) mentioned, we still need further investigations to determine the significance of BNI substaging because of the rarity of this population.
